No Detail Found!

Synthesis, characterization and in-vitro cytotoxic potential of sitagliptin phosphate nanoparticles against advanced breast cancer cell line - MCF-7

Author(s)
Muhammad Abdullah Department of Pharmacy, Punjab University College of Pharmacy, University of the Punjab,Lahore,Pakistan
Azra Rafiq Department of Pharmacy, University of Lahore, Lahore, Pakistan; Department of Pharmacy, Riphah International University, Lahore, Pakistan
Nariman Shahid Department of Pharmacy, University of Lahore,Lahore,Pakistan
Muhammad Nasir Kalam Department of Pharmacy, The Sahara University,Narowal,Pakistan
Yusra Munir Department of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Muhammad Daoud Butt School of Pharmaceutical Sciences,Universiti Sains Malaysia,Malaysia
Hamid Saeed Department of Pharmacy, University of Lahore,Lahore,Pakistan
Abstract
Pharmaceutical substance sitagliptin has long been used to treat diabetes. However, subsequent researches have shown that sitagliptin has additional therapeutic effects. Anti-inflammatory effects are observed. Combining sitagliptin with biodegradable polymers like nanoparticles for chemotherapy may be effective. This method enhances therapeutic agent pharmacokinetics. This study tests sitagliptin (SIT) chitosan base nanoparticles against MCF-7 cancer cell lines for anti-cancer effects. Sitagliptin chitosan-based nanoparticles are tested for their ability to suppress MCF-7 cancer cell proliferation. Ionic gelation, a typical nanoparticle manufacturing method, was used. A detailed examination of the nanoparticles followed, using particle-size measurement, FTIR, and SEM. Entrapment efficiency, drug-loading, and in-vitro drug release were assessed. Loaded with chitosan and sitagliptin, the nanoparticles averaged 500nm and 534nm in diameter. Sitagliptin has little effect on particle size. Chitosan-based Sitagliptin nanoparticles grew slightly, suggesting Sitagliptin is present. SIT-SC-NPs had 32% encapsulation efficiency and 30% drug content due to their high polymer-to-drug ratio. SEM analysis showed that both drug-free and sitagliptin-loaded nanoparticles are spherical, as shown by the different bands in the photos. The SIT-CS-NPs had a 120-hour release efficiency of up to 80%. This suggests that these nanoparticles could cure hepatocellular carcinoma, specifically MCF-7 cell lines.
Publication Details
Page(s) 1849-1858
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S6, Year: 2023

Request the full text from PASTIC

Keywords
Sitagliptin, Chitosan nanoparticles, MCF-7 cell lines, nanoparticle-based chemotherapy, advanced breast cancer, in-vitro cytotoxicity
0

Citations

0

Downloads

76

Views